Health Care & Life Sciences » Pharmaceuticals | Samrat Pharmachem Ltd.

Samrat Pharmachem Ltd. | Cash Flow

Fiscal year is April-March. All values INR Thousands.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
4,074.70
4,790.60
4,487.20
24,933.30
-
Depreciation, Depletion & Amortization
3,308.50
4,375.50
4,433.70
6,948.10
-
Other Funds
430.80
2,034.90
548.30
4,414.80
-
Funds from Operations
6,952.30
7,131.30
8,372.60
27,466.60
36,289.00
Changes in Working Capital
33,758.00
10,966.50
4,585.60
65,750.50
-
Net Operating Cash Flow
40,710.30
3,835.20
12,958.20
38,283.90
-
Capital Expenditures
40,598.00
1,745.10
5,184.50
6,264.70
-
Sale of Fixed Assets & Businesses
35,146.20
92.60
98.60
-
-
Purchase/Sale of Investments
-
-
20,010.00
20,229.00
-
Net Investing Cash Flow
5,451.90
1,652.50
25,095.90
13,964.30
-
Issuance/Reduction of Debt, Net
11,594.10
1,285.20
22,974.10
13,939.30
-
Net Financing Cash Flow
11,594.10
1,285.20
22,974.10
13,939.30
-
Net Change in Cash
23,664.40
4,202.60
10,836.40
10,380.40
-
Free Cash Flow
112.30
5,580.30
8,218.40
44,548.60
-

About Samrat Pharmachem

View Profile
Address
701/702, Business Square
Mumbai Maharashtra 400058
India
Employees -
Website http://www.samratpharmachem.com
Updated 09/14/2018
Samrat Pharmachem Ltd. engages in the manufacture of iodine and bromine salts. Its products include 3-5-Di iodosalicylic acid, aluminium iodide, clioquinol, ethylenediamine dihydroiodide, and barium, copper, and zinc iodide. The company was founded by Lalit Damodar Mehta on June 16, 1992 and is headquartered in Mumbai, India.